Group leader at Josep Carreras Institute For updates on the lab and the wider scientific community follow us on Bsky. #chromatin #leukaemia
IJC, Badalona, Barcelona, ES
Joined September 2017
- Tweets1.8K
- Following478
- Followers1.7K
- Likes873
OPPORTUNITY TO JOIN US!
We are looking for motivated PhD candidate who would like to work on improving blood cancer therapy. This is a mechanistic / translational project funded through Marie Sklodowska Curie Actions.
More info and how to apply here: carreraspathfinders.eu
Marcus Buschbeck and Lab retweeted
🔬 We’re hiring 3 Group Leaders in Paediatric Haematologic Malignancies.
🤝 @CarrerasIJC & @IRSJD_info are joining forces to launch a new translational research hub focused on paediatric blood cancers.
📝 Apply now to drive real change for young patients: f.mtr.cool/qncnupettq
Opportunity!
Are you interested in project and grant management? Consider joining us in Badalona and help us in our mission to cure blood cancer!
We’re hiring at the IJC 🚀
🔸 Head of the Research Grants Office
🔸 International Project Manager
👉 Apply here: careers.carrerasresearch.org
Be part of bridging science and real impact in blood cancer research 🧬
Marcus Buschbeck and Lab retweeted
Definitely no abstract submission deadline extension this year……but double the number of slots for short talks. One week to go to submit!
🕰️ There is still time to share your research at #ISEH2026! Submit by 17 April to be considered. Please note that no extensions will be offered.
Learn more and submit: iseh.org/Annual-Meeting/Abst…
MEET THE LAB
Paula, Jeannine, Marina and Marcus are in Finland attending the @EHA_Hematology Research Conference #EHAReCon2026 "From cradle to grave: normal and malignant hematopoiesis in young and aged settings".
For our presentations, come and check out Poster 44 & Poster 68!
Great opportunity for senescence aficionados to share results and network in Spain's most beautiful university town!
Two opportunities across two continents to connect with the cellular senescence community in 2026 🌍!
Excited to be part of the organizing team for the @YicsaC #Salamanca Symposium.
See you there!
#senescence #EarlyCareerResearchers
Marcus Buschbeck and Lab retweeted
Two opportunities across two continents to connect with the cellular senescence community in 2026 🌍!
Excited to be part of the organizing team for the @YicsaC #Salamanca Symposium.
See you there!
#senescence #EarlyCareerResearchers
🚨 SAVE THE DATE – @YicsaC Symposia 2026
For the first time, we will host meetings in US and Spain for early-career researchers in cellular senescence.
📅 May 11 – yICSA Mayo Clinic. More info coming soon!
📅 Sept 15–16 – yICSA Salamanca (@ciccancer), ahead of @SENESCEL
Marcus Buschbeck and Lab retweeted
Applications are now open to join an EHA Committee in 2026.
Across the hematology community, progress happens when committed individuals come together to share their expertise, challenge perspectives, and move our mission forward. At EHA, our Committees are at the heart of this work — shaping strategy, driving initiatives, and ensuring our association evolves in step with the needs of hematologists worldwide.
There are 20 vacancies open across 8 Committees. Submit your application by March 16, 2026, to take an active role in shaping the future of hematology: ehaweb.org/about-eha/get-inv…
Marcus Buschbeck and Lab retweeted
🚀 We’re Hiring!
16 PhD opportunities in experimental hemato-oncology!
Are you ready to translate fundamental discoveries into innovative therapeutic strategies and diagnostic tools?
📎Learn more & apply now: achilles-dn.eu/
#PhD #CancerResearch #MSCA #HematoOncology
New page of Buschbeck lab on LinkedIN.
After having used my private account on X/twitter for year for posting news about our research lab, we have now a brand-new site of the lab on LinkedIN. Consider following us there.
linkedin.com/company/buschbe…
Our lab is growing find out who joined us here:
linkedin.com/company/buschbe…
Or here:
buschbecklab.org
Interested in how to apply epigenetic knowledge for medicine?
Here a great opportunity for a 2026 conference in Badalona - Barcelona.
Coorganized by José Luis Sardina and hosted by @CarrerasIJC.
CLEPIC — what is it?
🔬 annual epigenetics meeting (molecular + clinical)
🌐 by @isMOCLEP (More: ismoclep.org)
📍In 2026 hosted by: @CarrerasIJC
📢 plenaries, posters, workshops, networking
🤝 connects scientists, clinicians, industry & policymakers
PhD opportunity!
Combine imaging and organoids to study how metabolism determines cell fate with an excellent PI in the vibrant student city of Utrecht!
As a plus you will become a fellow of the @NuclearDn network of 17 PhD students across Europe and beyond.
👇
🚀 PhD Opportunity in the NUCLEAR Doctoral Network!
🎓 Eligibility: Applicants must meet the MSCA mobility rule.
📩 Deadline 11 Dec. Apply here:
lnkd.in/eKM8JKeE
🔗 Learn more about our lab: rodriguezcolmanlab.org
Please share within your networks! 🌍🧬
PhD opportunity
An opportunity to do a PhD at the intersection of industry and academia while being part of a vibrant network.
👇
📢 Last chance to join the NUCLEAR project!
@eisbachbio is seeking a motivated PhD student to study NAD+ modulation of PARP1/2 in cancer research.
Deadline application: November 27.
Apply here: eisbach.bio/#1753279074422-a…
Marcus Buschbeck and Lab retweeted
📢 Last chance to join the NUCLEAR project!
@eisbachbio is seeking a motivated PhD student to study NAD+ modulation of PARP1/2 in cancer research.
Deadline application: November 27.
Apply here: eisbach.bio/#1753279074422-a…
NEW PAPER
We have dissected the physiological role of all macroH2A histone variants. In mice, loss of macroH2A1.1 results in profound metabolic reprogramming and kidney pathology.
DOI: 10.1126/sciadv.adz1242
1/7
6/7
Conclusion: Chromatin composition integrates with metabolic regulation at the NAD⁺ interface. Loss of macroH2A1.1 decouples chromatin–mitochondrial crosstalk, shifting nutrient flux toward glycolysis and instigating secondary organ dysfunction.
We would like to thank:
- Our collaborators @bernstein_lab, @Mandie555
and @POberdoerfferfor for advice and samples.
- Our editor Navdeep Chandel @NUFeinbergMed for his guidance.
- And most importantly, all members of my lab for support on all levels.